All articles by Andrew Turley – Page 7
-
BusinessThe future of PVC production?
Commercial interest in a semi-continuous approach seems to be on the rise
-
Business
Drug spending to hit $1.2tn in 2016
Growth is expected to bottom out at 3–4% for 2012 and then rise to 5–7% for 2016
-
Business
GSK drug shines in HIV trial
HIV–Aids drug candidate dolutegravir outperformed Atripla tablets in Phase III
-
BusinessInterview: EMA head Guido Rasi
Guido Rasi, head of the European Medicines Agency, wants to see greater transparency in drug development
-
Business
Is Sanofi cutting jobs in France?
News outlets are reporting plans to cut 1000-2000 employees in France
-
Business
Brazil hits BASF with worker payout
BASF and Shell have been ordered to pay BRL1 billion (£300 million) to compensate employees for damage to their health
-
Business
Bayer buys crop protection firm for $425m
Bayer has struck a deal to buy US pest control products firm AgraQuest
-
Business
BMS and AstraZeneca buy Amylin for $7bn
Two pharma giants have teamed up to buy US biotech Amylin, responsible for the Byetta and Bydureon anti-diabetes brands
-
Business$3bn GSK fine sets new industry record
The fine relates to off label marketing and is the largest payment of its kind ever made by a drug company
-
Business
US GM labelling rule quashed
The rule would have authorised state governments to enforce GM labels on food products
-
BusinessIndustrial nitroglycerin made fast and safe
Continuous production with microreactors is not only safer but also ten times quicker
-
Business
Nasonex patent ruling goes against Merck & Co
The court ruled that the Merck patent was valid - but Apotex won’t infringe it with its product
-
Business
New US R&D site for silicones
Bluestar Silicones opens expanded site in York, South Carolina
-
Business
Lundbeck to lose 600 jobs
Danish drug maker Lundbeck has said it will cut 600 jobs as it reorganises its European operations
-
Business
ECHA finishes first combo review
The European Chemical Agency has looked at a group of phthalates as a combination when considering risks associated with exposure
-
Business
Good signs for Merck & Co insomnia pill
Suvorexant switches off wakefulness to help patients drop off quicker and stay asleep longer
-
Business
Coca-Cola collaborates on bio-PET project
Global drinks giant Coca-Cola is teaming up with Ford, Heinz, Nike and Procter & Gamble to increase the use of bio-based polyethylene terephthalate
-
Business
Plastics makers to win from electric cars
Demand for lightweight plastics in electric vehicles to hit $73 million by 2017
-
Business
UK nuclear fuel site faces 2018 closure
The Thermal Oxide Reprocessing Plant (Thorp) at Sellafield in the UK will close in 2018